## Diagnosis: Complete Hydatidiform Mole ### Clinical Presentation **Key Point:** The clinical triad of markedly elevated β-hCG (often >100,000 mIU/mL), uterine enlargement disproportionate to gestational age, and vaginal bleeding is pathognomonic for complete mole. ### Ultrasound Findings The **'bunch of grapes'** appearance (multiple small anechoic spaces within echogenic tissue) is the classic ultrasound hallmark of complete hydatidiform mole. This represents hydropic villi. ### Karyotype & Pathology | Feature | Complete Mole | Partial Mole | |---------|---------------|---------------| | Karyotype | 46,XX (90%) or 46,XY (10%) — diploid, biparental | 69,XXX or 69,XXY — triploid, diandric | | Fetal tissue | Absent | Present (rudimentary fetus/amnion) | | β-hCG level | Very high (>100,000) | Moderately elevated | | Theca lutein cysts | Common (>50%) | Rare | | Malignant potential | 15–20% (choriocarcinoma) | 1–5% | | Uterine size | Larger than dates | Smaller than dates | **High-Yield:** Complete moles are entirely of paternal origin (androgenetic) — either duplication of a single sperm (90%) or fertilization by two sperm (10%). Partial moles are triploid with diandric contribution. ### Why Complete Mole Here 1. **No fetal parts** on ultrasound → rules out partial mole 2. **Markedly elevated β-hCG** (450,000) → typical of complete mole 3. **Uterus enlarged beyond dates** → complete mole 4. **'Bunch of grapes' pattern** → diagnostic of complete mole 5. **No theca lutein cysts mentioned** → less common in complete mole but absence does not exclude it ### Management **Clinical Pearl:** After evacuation by suction curettage, close follow-up with serial β-hCG is mandatory because 15–20% of complete moles progress to persistent gestational trophoblastic neoplasia (PGTN) or choriocarcinoma. **Mnemonic: CHOP** — **C**omplete mole has **H**igh hCG, **O**ften no fetus, **P**aternal origin only. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.